All stories tagged :

Pr Newswire

Immuthera’s Scientific Advisory Board: World-Leading Expertise Driving Next-Generation Diabetes and Immunotherapy...

admin
Pr Newswire

Alterity Therapeutics to Present at the MST Access ‘Hidden Gems in...

admin
Pr Newswire

Connect Biopharma Announces Inducement Grants under Nasdaq Listing Rule 5635(c)(4)

admin
Pr Newswire

Dentsply Sirona Provides Update on June Investor Conference Participation

admin
Pr Newswire

Cellectis Unveils a Non-Viral Gene Therapy Approach for Sickle Cell Disease in...

admin
Pr Newswire

Connect Biopharma Announces New Leadership and Chair of the Board of...

admin
Pr Newswire

Tompkins Robotics Announces Expanded Capabilities in the Australian Market, as Primary...

admin
Pr Newswire

SEMIFIVE Collaborates with OPENEDGES on Chiplet Development

admin
Pr Newswire

Azazie, the Leading DTC Bridal Brand, Unveils the Ultimate Destination Wedding...

admin
Pr Newswire

Cango Inc. Reports First Quarter 2024 Unaudited Financial Results

admin
Pr Newswire

Aesthetic procedures close to 35 million in 2023

admin

Featured

Pr Newswire

Virbac : Declaration of the number of shares and voting rights...

admin
Pr Newswire

Nxera Pharma to Receive US$4.8 Million in Milestone Payments Following Centessa’s...

admin
Pr Newswire

AB Science: Masitinib receives FDA and EMA authorization for confirmatory phase...

admin
Pr Newswire

Strüngmann Award Honors Araris Biotech Founding Team as 2025 Winner

admin
admin

Virbac : Declaration of the number of shares and voting rights...

DECLARATION OF THE NUMBER OF SHARES AND VOTING RIGHTS Information on the total number of voting rights and of shares representing the share capital(Article 223-16 of the General regulations of the French Financial Market Authority – Autoritédes Marchés Financiers) Quotation place: Euronext ParisCompartiment AISIN code: FR0000031577 DateTotal...